139 related articles for article (PubMed ID: 2540110)
1. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D
J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992
[TBL] [Abstract][Full Text] [Related]
3. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
[No Abstract] [Full Text] [Related]
4. Murine models for evaluating antiretroviral therapy.
Ruprecht RM; Bernard LD; Gama Sosa MA; Sosa MA; Fazely F; Koch J; Sharma PL; Mullaney S
Cancer Res; 1990 Sep; 50(17 Suppl):5618S-5627S. PubMed ID: 2167158
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity.
Ruprecht RM; Bronson R
DNA Cell Biol; 1994 Jan; 13(1):59-66. PubMed ID: 8286040
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with a live retrovirus: the nature of the protective immune response.
Ruprecht RM; Mullaney S; Bernard LD; Gama Sosa MA; Hom RC; Finberg RW
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5558-62. PubMed ID: 2371289
[TBL] [Abstract][Full Text] [Related]
7. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
Hoover EA; Zeidner NS; Perigo NA; Quackenbush SL; Strobel JD; Hill DL; Mullins JI
Intervirology; 1989; 30 Suppl 1():12-25. PubMed ID: 2540109
[TBL] [Abstract][Full Text] [Related]
8. Suppression of retroviral propagation and disease by suramin in murine systems.
Ruprecht RM; Rossoni LD; Haseltine WA; Broder S
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7733-7. PubMed ID: 2415971
[TBL] [Abstract][Full Text] [Related]
9. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.
Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D
Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597
[TBL] [Abstract][Full Text] [Related]
10. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy.
Bowden R; Tate SM; Soto S; Specter S
Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002
[TBL] [Abstract][Full Text] [Related]
11. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation therapy using resistant donors for retrovirus-induced leukaemia in mice.
Iwai H; Day NK; Hamada N; Inaba MM; Ikehara S; Good RA
Clin Exp Immunol; 1994 Jan; 95(1):135-40. PubMed ID: 8287597
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo enhancement of ddI activity against Rauscher murine leukemia virus by ribavirin.
Allen LB; Quenelle DC; Westbrook L; Taylor BA; Prichard MN; Brazier AD; Hollingshead MG; Shannon WM
Antiviral Res; 1995 Jun; 27(3):317-23. PubMed ID: 8540752
[TBL] [Abstract][Full Text] [Related]
14. Imexon and biological response modifiers in murine models of AIDS.
Chirigos MA; Ussery MA; Black PL
Int J Immunopharmacol; 1991; 13 Suppl 1():33-41. PubMed ID: 1823906
[TBL] [Abstract][Full Text] [Related]
15. Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model.
Basham T; Rios CD; Holdener T; Merigan TC
J Infect Dis; 1990 May; 161(5):1006-9. PubMed ID: 2157768
[TBL] [Abstract][Full Text] [Related]
16. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease.
Specter S; Plotnikoff N; Bradley WG; Goodfellow D
Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296
[TBL] [Abstract][Full Text] [Related]
17. Antileukemic activity of Viva-Natural, a dietary seaweed extract, on Rauscher murine leukemia in comparison with anti-HIV agents, azidothymidine, dextran sulfate and pentosan polysulfate.
Furusawa E; Furusawa S; Chou SC
Cancer Lett; 1991 Mar; 56(3):197-205. PubMed ID: 1708693
[TBL] [Abstract][Full Text] [Related]
18. Modulation of fas/fasL in a murine retroviral infection by AZT and methionine enkephalin.
Bowden R; Soto S; Specter S
Adv Exp Med Biol; 2001; 493():143-52. PubMed ID: 11727760
[No Abstract] [Full Text] [Related]
19. Optimization of the reverse transcriptase assay for the detection of viral burden in mice infected with Rauscher murine leukemia virus.
White EL; Westbrook L; Hollingshead MG; Shannon WM
J Virol Methods; 1996 Oct; 62(1):63-70. PubMed ID: 8910649
[TBL] [Abstract][Full Text] [Related]
20. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
